Compare ProShares UltraPro Short QQQ ETF (SQQQ) vs Stryker Corporation (SYK) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
ProShares UltraPro Short QQQ ETF vs Stryker Corporation — how do they compare? ProShares UltraPro Short QQQ ETF trades at $40.28, while Stryker Corporation trades at $314.62 (market cap $122.35B). The key difference: Stryker Corporation pays a 1% dividend while ProShares UltraPro Short QQQ ETF pays none, and Stryker Corporation is trading nearer its 52-week high, ProShares UltraPro Short QQQ ETF nearer its low. Which is the better fit depends on your goals.
| SQQQ | SYK | |
|---|---|---|
Sector | Leveraged / Inverse | Technology |
52-Week High | $97.60 | $403.53 |
52-Week Low | $36.31 | $282.58 |
Market Cap | — | $122.35B |
Enterprise Value | — | $134.10B |
Dividend Yield | — | 1% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About ProShares UltraPro Short QQQ ETF
SQQQ is a leveraged inverse ETF that seeks daily investment results, before fees and expenses, that correspond to three times the inverse (-3x) of the daily performance of the Nasdaq-100 Index. It is a tactical trading tool designed for sophisticated investors to profit from or hedge against declines in large-cap technology and growth stocks. Due to its daily reset and the effects of compounding, it is intended for short-term use and carries significant risk if held during periods of high market volatility.
Read more on SQQQ →About Stryker Corporation
Stryker is a global leader in medical technology, specializing in Orthopaedics, MedSurg, and Neurotechnology. It is renowned for its highly decentralized business model, which empowers 22 specialized business units to drive innovation and category leadership. With its market-leading Mako SmartRobotics™ platform and a relentless M&A strategy, Stryker provides a comprehensive ecosystem of connected surgical tools, implants, and digital solutions that improve both clinical and financial outcomes for hospitals worldwide.
Read more on SYK →
